Exclusive: Ryan Prior Talks Upcoming Book, The Long Haul
OMF sat down with journalist, producer & patient activist Ryan Prior to chat about his upcoming book, The Long Haul.
Post-infectious conditions require knowledge management
Publication from Jonas Bergquist, PhD & colleagues: Post-infectious conditions require knowledge management
Survey Participation Request: ME/CFS Survey from The Norwegian ME Association
Please help the Norwegian ME Association gather crucial information about ME/CFS by filling out their survey!
OMF Featured in Inside Philanthropy!
Open Medicine Foundation is proud to share that our work has been featured in Inside Philanthropy, a leading source of nonprofit news: “Boosting Research into Long COVID and ME/CFS.”
OMF Honors Severe ME Day 2022
August 8, 2022, marks Severe ME/CFS Day. On this day of recognition, Open Medicine Foundation shines a bright light on all those who live in darkness.
Big News! Announcing our 7th Center in Partnership with Bateman Horne Center
Open Medicine Foundation announces the launch of a new center to advance ME/CFS medical education in partnership with Bateman Horne Center!
Raman Spectrometry Based Biomarker Discovery for Myalgic Encephalomyelitis (RASPBERRY-ME)
The overarching goal of RASPBERRY-ME project is the characterization of the biomolecular signature of Myalgic Encephalomyelitis using Label-free Raman Spectroscopy (RS) and machine learning models.
Study of COVID-19 survivors’ profiles for detection of ME/CFS (SCOPIMED)
The purpose of this study is to capture a post-COVID-19 infected population willing to participate in phenotyping studies early in the post-COVID-19 illness progression, with an aim of providing targeted effective therapies and preventing the onset and progression of ME/CFS.
Multi-Omics Study of ME/CFS (MAESTRO)
The primary goal of this project is to complete our comprehensive analysis of the genome, methylome, miRnome, and their interactions in order to fill the gaps in our understanding of ME/CFS pathophysiology and to identify clinically useful biomarkers.
Precision Medicine for Myalgic Encephalomyelitis Drug Discovery
The REMEDIAL project continues the work commenced with MAESTRO and will lead to a better understanding of the molecular mechanisms underlying ME/CFS pathophysiology, the persistence and variability of the symptoms, and will contribute to the identification of targets and therapeutic agents for intervention.
Ron Davis ME/CFS Research Update: DNA/RNA Technology
Metadescription: Ron Davis discusses how DNA & RNA technology is being developed at Stanford to advance research into ME/CFS, Long COVID, and related diseases.
Video Update from Rob Phair: The Itaconate Shunt Hypothesis for ME/CFS
Robert Phair, PhD gives a video update on the Itaconate Shunt Hypothesis for ME/CFS, a study in collaboration with Christopher W. Armstrong, Ron Davis, PhD, and Ron’s team at Stanford.
